Endotoxaemia Completed Phase 4 Trials for Vasopressin (DB00067)

Also known as: Endotoxemia / Endotoxemia (disorder)

IndicationStatusPhase
DBCOND0014110 (Endotoxaemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02675868Effects of Vasopressors on Immune ResponseBasic Science